中医药防治急性心肌梗死再灌注后无复流的优势探讨  

Advantages of traditional Chinese medicine in treating myocardial no-reflow after acute myocardial infarction/reperfusion

作　　者：张金艳[1] 李少春[1] 李贻奎[1] 赵乐[1] 翁维良[1] 李连达[1] 

机构地区：[1]中国中医科学院西苑医院李连达院士研究室,北京100091

出　　处：《中国新药杂志》2015年第3期276-280,共5页Chinese Journal of New Drugs

基　　金：中国博士后特别资助项目(2012T50202)

摘　　要：经皮冠脉介入治疗急性心肌梗死后,常出现心肌无复流现象,严重影响患者预后,因其发生机制复杂,至今尚无理想的标准治疗措施。近年来所尝试的器械干预和西医药物治疗等手段,因其作用环节单一,临床疗效有限,所带来的临床益处也尚存争议。本文就中医药防治急性心肌梗死再灌注后无复流的优势进行分析和探讨,为中医药防治无复流的新药研发提供思路和信心。Myocardial no-reflow often occurs after percutaneous coronary intervention for acute myocardial infarction, seriously affecting the prognosis of patients. The mechanism of no fellow is complex and not completely clear. Thus, there is no ideal standard treatment for myocardial no reflow. In recent years, many attempts on in- strument intervention and western medicine treatment have been carried out, but no ideal strategy has been estab- lished. In this paper, the advantages of traditional Chinese medicine on myocardial no-reflow after acute myocardial infarction/reperfusion were discussed.

关 键 词：心肌缺血 再灌注 无复流 中药 

分 类 号：R285[医药卫生—中药学]